K. Medvik

发表

IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.

M. Lederman, M. Proschan, J. Altman, 2009, Blood.

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

M. Lederman, J. Mellors, J. Coffin, 2010, PLoS medicine.

Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication.

M. Lederman, P. Kiser, M. Quiñones-Mateu, 2003, AIDS.

infection cycle entry and expansion in HIV-1 - IL-7 administration drives T cell

M. Proschan, J. Altman, M. Fischl, 2011 .

Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells.

M. Lederman, G. McComsey, S. Sieg, 2011, The Journal of infectious diseases.

Impaired Surface Membrane Expression of C3bi but Not C3b Receptors on Neonatal Neutrophils

M. Bruce, M. Berger, K. Medvik, 1987, Pediatric Research.

Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection

M. Lederman, H. Valdez, C. Lange, 2003, AIDS.

CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection.

M. Lederman, H. Valdez, C. Lange, 2002, Clinical immunology.

Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229

Z. Su, J. Currier, G. McComsey, 2010, AIDS.

Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals.

D. Anthony, J. Aberg, E. Overton, 2011, Vaccine.

Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication

M. Lederman, P. Kiser, M. Quiñones-Mateu, 2003 .

Characteristics and Outcomes of Initial Virologic Suppressors during Analytic Treatment Interruption in a Therapeutic HIV-1 gag Vaccine Trial

M. Carrington, B. Walker, R. Schooley, 2012, PloS one.

Interferon-Alpha Administration Enhances CD8+ T Cell Activation in HIV Infection

R. Schooley, M. Lederman, D. Asmuth, 2012, PloS one.

Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138.

Hildegund C J Ertl, Laura Smeaton, Minya Pu, 2006, The Journal of infectious diseases.

Baseline levels of soluble CD14 and CD16+56- natural killer cells are negatively associated with response to interferon/ribavirin therapy during HCV-HIV-1 coinfection.

M. Lederman, D. Anthony, R. Blanton, 2012, The Journal of infectious diseases.

IFN/Ribavirin therapy during HCV-HIV-1 co-infection

M. Lederman, D. Anthony, M. Rani, 2012 .

Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function

J. Lieberman, M. Lederman, H. Valdez, 2004, AIDS.

In vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection.

H. Valdez, S. Sieg, B. Rodriguez, 2010, Clinical immunology.

Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5.

M. Lederman, J. Hoxie, T. Hope, 2011, Blood.

Circulating human CD 4 and CD 8 T cells do not have large intracellular pools of CCR 5

M. Lederman, J. Hoxie, T. Hope, 2011 .

Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.

M. Lederman, H. Valdez, C. Lange, 2002, Journal of acquired immune deficiency syndromes.

Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229

J. Currier, G. McComsey, J. Aberg, 2010, AIDS.